Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
Diasens and GlucoLive are designed for diabetic, Chronic Kidney Disease (CKD), and post-transplant patients who require continuous glycaemic surveillance and integrated remote care
Emcure to distribute Roche's kidney transplant and anemia drugs in India
The company said the move applies to all doses and reflects its commitment to making its medicines more affordable for patients
Subscribe To Our Newsletter & Stay Updated
